CHIEF MEDICAL EDITOR'S PAGE
By John R. Laird, Jr, MD
Endovascular Today interviews James D. Joye, DO, President of VIVA Physicians (VPI), regarding the group's multispecialty collaboration efforts, philanthropy, and annual meeting.
By James D. Joye, DO
IMAGING & DIAGNOSTICS
Development of an up-to-date operating room that will meet the demands of the vascular surgery patient and team.
By Matthew J. Eagleton, MD, and Jonathan L. Schaffer, MD, MBA
The past, present, and future of treating this disease.
By Jeffrey H. Freihage, MD, and Robert S. Dieter, MD, RVT
How to recognize and manage the risk factors and complications that can lead to limb ischemia in hospitalized patients.
By David L. Dawson, MD
The role of this treatment option in critical limb ischemia patients.
By Michael C. Nguyen, MBBS, and Lawrence A. Garcia, MD
A treatment option for critical limb ischemia.
By Rajesh M. Dave, MD, FACC, FSCAI
A new generation of long balloons for treating diabetics and nondiabetics.
By Lanfroi Graziani, MD
Novel technologies for endovascular management of infrapopliteal disease.
By Vinod Nair, MD, FACC, and Peter S. Fail, MD, FACC, FACP
An interim look the VIVA I/XCELL trial.
By Krishna Rocha-Singh, MD, FACC, FSCAI, on behalf of VIVA Physicians, Inc.
Two-year results from the Leipzig Cypher BTK registry.
By Dierk Scheinert, MD
Physical modifications and new tools to allow directional control of laser photoablative therapy and creation of larger lumens have become available since the LACI trial.
By Craig Walker, MD, FACC, FACP, and Vinod Nair, MD, FACC
A leading interventional radiologist explains the strength of multidisciplinary documents, the 5-year outlook for VTED, and why technology has an impact on decision making.